U.S. Beverage Stock News

If you are wondering whether Farmers & Merchants Bank of Long Beach is priced attractively at around US$8,435 per share, you are not alone. This article is built to help you frame that question clearly. The stock has been relatively steady in the short term, with a 0.2% 7 day decline and returns of 1.0% over 30 days, 1.9% year to date and 50.9% over the last year, plus 29.0% over 3 years and 24.3% over 5 years. Recent coverage of Farmers & Merchants Bank of Long Beach has focused on its...

If you are wondering whether Stryker's share price around US$386 still offers value, you are not alone; many investors are trying to work out what a fair price looks like today. Over shorter periods, the stock has seen returns of 3.6% over the last 7 days, 8.9% over the last 30 days and 10.9% year to date, while the 1 year return sits at 0.2% and the 3 and 5 year returns are 51.6% and 72.4% respectively. Recent news coverage around Stryker has mainly centered on its position as a large...

Synopsys (SNPS) has kicked off Q1 2026 with total revenue of US$2.4b and basic EPS of US$0.34, setting the stage against a trailing twelve month picture that includes US$8.0b in revenue and basic EPS of US$6.40. Over recent quarters, the company has reported revenue of US$1.46b in Q1 2025, US$1.60b in Q2, US$1.74b in Q3 and US$2.25b in Q4, while quarterly basic EPS over that period ranged from US$1.91 to US$2.42. With trailing net profit margins now at 13.8% and influenced by a large one off...

WisdomTree (NYSE:WT) received SEC approval to offer intraday trading and instant settlement for tokenized shares of its Treasury Money Market Digital Fund. The approval allows 24/7 trading of these tokenized money market fund shares in the U.S. This marks a first of its kind use of blockchain infrastructure for a registered U.S. mutual fund with continuous trading and immediate settlement. WisdomTree, known for its exchange traded products and digital asset initiatives, is moving deeper...

ACM Research FY 2025 Earnings Snapshot ACM Research (ACMR) has wrapped up FY 2025 with fourth quarter revenue of US$244.4 million and basic EPS of US$0.12, alongside trailing twelve month revenue of US$901.3 million and EPS of US$1.47. Over recent periods the company has seen quarterly revenue move from US$223.5 million and EPS of US$0.49 in Q4 2024 to a peak of US$269.2 million and EPS of US$0.56 in Q3 2025 before landing at current levels. This puts the spotlight squarely on how efficiently...

Host Hotels & Resorts (HST) has wrapped up FY 2025 with fourth quarter total revenue of US$1.6 billion and basic EPS of US$0.20, alongside funds from operations of US$340 million that remain the key gauge for this REIT. Over recent quarters, the company has seen revenue move from US$1.42 billion in Q4 2024 to US$1.60 billion in Q4 2025, while basic EPS shifted from US$0.15 to US$0.20. This gives investors a clearer view of how the top line and per share results are tracking into the latest...

If you are looking at Bausch Health Companies and wondering whether the current share price reflects its underlying value, you are not alone. The stock last closed at US$6.04, with returns of 1.9% over the past week and 5.6% over the past month, against year to date and 1 year returns of 16.2% and 21.0% declines, and a 34.7% and 81.1% decline over 3 and 5 years respectively. These moves have kept valuation in focus for many investors, especially as headlines continue to frame Bausch Health...

Teleflex (TFX) has just posted its FY 2025 fourth quarter numbers, with revenue of US$569 million and a basic EPS loss of US$0.08, while trailing twelve month revenue sits at US$2.0 billion and EPS at US$1.31. Over recent quarters, revenue has ranged from US$569 million to US$913 million, with quarterly basic EPS swinging between a loss of US$9.24 and a profit of US$2.77. This underscores how headline earnings have been heavily affected by discontinued operations and one off items. With...

If you are wondering whether TAL Education Group's share price still reflects its true value, you are not alone, especially given how different its past performance looks over various time frames. The stock last closed at US$10.89, with returns of 0.2% decline over 7 days, 2.3% over 30 days, a 5.2% decline year to date, a 17.9% decline over 1 year and 37.8% over 3 years, compared with a much larger 85.5% decline over 5 years. These mixed returns sit against a backdrop of ongoing regulatory...

Herbalife (NYSE:HLF) has launched a major refinancing of its senior secured debt, targeting a large portion of its existing obligations. The company is pairing this move with an update on product driven performance, highlighting strong momentum in markets such as India. Management is also emphasizing continued investment in its distributor network alongside ongoing product development. Herbalife comes into this refinancing with its shares at $19.28 and a mixed return profile. The stock is...

Payoneer Global FY 2025 Earnings Snapshot Payoneer Global (PAYO) has capped FY 2025 with fourth quarter total revenue of US$274.7 million and basic EPS of US$0.05, while trailing twelve month revenue sits at about US$1.1 billion alongside basic EPS of roughly US$0.20. Over recent periods, the company has seen quarterly revenue move from US$261.7 million in Q4 2024 to US$274.7 million in Q4 2025, with basic EPS shifting between US$0.05 and US$0.06 over the FY 2025 quarters. With trailing net...

IonQ (IONQ) has just wrapped up FY 2025 with fourth quarter revenue of about US$61.9 million and basic EPS of US$2.18, alongside trailing 12 month revenue of roughly US$130.0 million and basic EPS of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue range from US$7.6 million in early 2025 to US$39.9 million in the third quarter and then to US$61.9 million in the fourth quarter, while basic EPS has moved from a loss of US$0.93 in late 2024 to a loss of...

Lantheus Holdings (LNTH) has just closed out FY 2025 with Q4 revenue of US$406.8 million and basic EPS of US$0.82, alongside trailing twelve month revenue of about US$1.5 billion and basic EPS of US$3.46 that frame the latest quarter in a broader earnings context. Over the past few quarters, the company has seen revenue move from US$372.8 million in Q1 2025 to US$406.8 million in Q4 2025, while quarterly basic EPS shifted from US$1.06 to US$0.82 and trailing net profit margin sits at 15.2%...

Protagonist Therapeutics (PTGX) closed FY 2025 with Q4 revenue of US$7.4 million and a basic EPS loss of US$0.69, alongside a Q4 net loss of US$44.4 million. On a trailing twelve month basis, revenue was US$46.0 million with a basic EPS loss of US$2.05 and a net loss of US$130.1 million. The company has reported quarterly revenue ranging from US$28.3 million in Q1 2025 down to US$4.7 million in Q3 2025. Basic EPS moved from a loss of US$0.19 in Q1 to a loss of US$0.62 in Q3 before reaching a...

In February 2026, Camping World Holdings reported fourth-quarter and full-year 2025 results showing quarterly revenue of US$1,173.56 million and a widening net loss of US$67.3 million, alongside a full-year net loss of US$89.8 million despite higher annual revenue of US$6,369.15 million. At the same time, the board paused Camping World’s regular quarterly cash dividend to prioritize reducing net debt leverage amid tax law changes and weaker profitability, marking a significant shift in how...

Recently, Jim Cramer praised EZCORP, Inc. (NASDAQ: EZPW) on his show as a well-run pawn and credit business, while EZCORP’s chief revenue officer highlighted strong customer interest in selling gold amid near-record prices. Taken together, this favorable media attention and management commentary on gold-driven activity underscore how closely EZCORP’s pawn operations are linked to movements in precious metals markets. We’ll now explore how upbeat commentary on EZCORP’s operations and...

Joby Aviation (JOBY) has just wrapped up FY 2025 with Q4 revenue of US$30.8 million and a basic EPS loss of US$0.14, alongside trailing twelve month revenue of US$53.4 million and a TTM basic EPS loss of US$1.13. Over recent quarters, the company has moved from effectively zero revenue in early 2025 to US$22.6 million in Q3 and US$30.8 million in Q4. Quarterly basic EPS losses ranged between US$0.11 and US$0.48. This sets up a story where top line traction is building against a backdrop of...

CubeSmart recently reported fourth-quarter and full-year 2025 results showing higher revenue, as sales rose to US$240.93 million for the quarter and US$956.65 million for the year, but net income and earnings per share declined compared with 2024. Alongside affirming a US$0.53 quarterly dividend for April 2026, management issued 2026 guidance that points to flat to slightly negative same-store revenue and net operating income growth, highlighting a more cautious near-term outlook for the...

If you are wondering whether First Financial Bankshares is reasonably priced or you might be overpaying at US$33.45, you are asking the right question before making any decisions. The share price has moved 1.1% over the last week, 5.1% over the past month, and 11.4% year to date, while the 1 year return sits at an 8.2% decline and the 3 and 5 year returns are 0.5% and 18.0% declines respectively. Recent coverage has focused on broad sector trends and regional bank conditions, which helps...

This article is designed to help you assess whether Innodata's share price aligns with its underlying worth, or if sentiment has run ahead of fundamentals. Innodata last closed at US$47.58, with a 4.3% return over the past week, an 18.9% decline over the past month, a 10.2% decline year to date, a 9.6% decline over 1 year and a very large 3 year and 5 year return that is more than 7x. Recent headlines around Innodata have focused on its role in data engineering and AI related services,...

If you are wondering whether 10x Genomics is priced attractively at its current level, this article walks through how its value stacks up using several common yardsticks. The stock last closed at US$22.13, with returns of 15.3% over the past 7 days, 2.4% over 30 days, 33.2% year to date and 105.3% over 1 year, set against longer term returns of a 54.1% decline over 3 years and an 85.0% decline over 5 years. Recent news flow around 10x Genomics has focused on its position in single cell and...

ADMA Biologics (ADMA) has capped FY 2025 with fourth quarter revenue of US$139.2 million and basic EPS of US$0.21, while trailing twelve month revenue sits at US$510.2 million and EPS at US$0.62. The company has seen quarterly revenue move from US$117.5 million in Q4 2024 to US$139.2 million in Q4 2025, with basic EPS shifting from US$0.47 to US$0.21 over the same period. This sets up a results season where growth expectations and margin quality are front of mind for investors. See our full...

HEICO (HEI) opened fiscal 2026 with Q1 revenue of US$1.2 billion and basic EPS of US$1.36, supported by trailing 12 month net income of US$712.6 million and EPS of US$5.12, alongside 25.6% year over year earnings growth and a 20.1% earnings CAGR over five years. The company has seen revenue move from US$3.9 billion to US$4.6 billion and trailing 12 month net income rise from US$514.1 million to US$712.6 million, with earnings growth of 25.6% over the last year and forecasts calling for about...

Nutanix (NTNX) just posted Q2 2026 results with revenue of US$722.8 million and basic EPS of US$0.38, alongside net income of US$103.0 million, while the trailing twelve months show revenue of US$2.7 billion and basic EPS of US$0.99 on net income of US$267.1 million. Over recent quarters the company has seen revenue move from US$590.9 million in Q1 2025 to US$670.6 million in Q1 2026 and US$722.8 million in Q2 2026. Basic EPS has shifted from US$0.11 to US$0.23 and then US$0.38, which may...